Albert Park
Dr. Park is the past division chief of pediatric otolaryngology at the University of Utah, the current endowed presidential chair for research and director of the multidisciplinary pediatric hearing center. He has had a long-standing interest in pediatric hearing loss. His team has implemented a state-wide expanded targeted early cytomegalovirus (CMV) screening for newborns, a multi-disciplinary congenital CMV clinic for children diagnosed with this condition, the first clinically validated dry blood spot and saliva PCR assays and a murine model to study CMV mediated hearing loss.
Sessions
Nearly 100 million children worldwide are affected by hearing loss, with congenital unilateral hearing loss diagnosed in up to 1 in 1,000 births in developed countries. Management of this condition varies significantly across the globe, influenced by factors such as resource availability, access to care, and ethical considerations.
key challenges in managing congenital unilateral hearing loss include determining the appropriate timing and type of intervention, selecting the most suitable devices, and identifying the right candidates. Traditional outcome measures used for bilateral hearing loss may not fully capture the experiences or benefits for the children with unilateral hearing loss and consistent auditory input in one ear. For this population, additional metrics, such as quality of life, listening effort, and fatigue, must be considered.
this international expert panel will explore current global practices in managing congenital unilateral hearing loss and highlight key insights to inform shared decision-making with families.